Genmab reported 384M in Loan Capital for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Loan Capital Change
Agios Pharmaceuticals AGIO:US $ 0.17M 0.08M
Alexion Pharmaceuticals ALXN:US $ 2388.8M 30.8M
Amarin AMRN:US $ 0M 0M
Amgen AMGN:US $ 28458M 2671M
AstraZeneca AZN:LN 24601M 6727M
Bayer BAYN:GR € 36664M 1254M
Biomarin Pharmaceutical BMRN:US $ 1077.11M 0.98M
Bluebird Bio BLUE:US $ 0M 0M
Exelixis EXEL:US $ 0M 0M
Fresenius Medical Care FME:GR € 10469M 133M
Galapagos GLPG:NA 21.43M 747K
Genmab GEN:DC 384M 58M
GlaxoSmithKline GSK:LN 20442M 2605M
GN Store Nord GN:DC 5.75B 18M
GRIFOLS GRF:SM € 6978M 247.04M
H. Lundbeck A/S LUN:DC 5.71B 42M
Hikma Pharmaceutical HIK:LN 751M 13M
Immunogen IMGN:US $ 0M 0M
Insmed INSM:US $ 562.86M 186.87M
Lonza Group LONN:SW 2.79B 5M
Merck MRK:GR € 8721M 280M
Novartis NOVN:VX SF 26491M 908M
Regeneron Pharmaceuticals REGN:US $ 1979.2M 0.3M
Seattle Genetics SGEN:US $ 0M 0M
William Demant Holding WDH:DC 4.96B 26M